 | | PRD_001101 | | Name: | N-(benzylsulfonyl)-D-valyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | | Formula: | C25 H33 N5 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000325 | | Name: | Nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(3S)-1-phenyl-5-(phenylsulfonyl)pentan-3-yl]-L-phenylalaninamide | | Formula: | C32 H40 N4 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000326 | | Name: | cyclo(L-alpha-aspartyl-L-tryptophyl-L-alpha-glutamyl-L-phenylalanyl-D-prolyl-L-prolyl-L-phenylalanyl-L-alpha-glutamyl-6-chloro-L-tryptophyl-L-leucyl) | | Formula: | C70 H81 Cl N12 O16 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001103 | | Name: | TMC-95A mimic ligand 2a | | Formula: | C42 H47 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000328 | | Name: | N-[(benzyloxy)carbonyl]-L-alanyl-N-{(1S)-1-[(R)-[(1R)-1-benzyl-2-methoxy-2-oxoethoxy](hydroxy)phosphoryl]-3-methylbutyl
}-L-alaninamide | | Formula: | C29 H40 N3 O9 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000329 | | Name: | N~2~-[(benzyloxy)carbonyl]-N-[(1R,2S)-1-(dihydroxyboranyl)-2-methylbutyl]-L-alaninamide | | Formula: | C16 H25 B N2 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001105 | | Name: | TMC-95A mimic ligand 2c | | Formula: | C42 H47 N5 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000330 | | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | | Formula: | C30 H41 N5 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001107 | | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | | Formula: | C95 H147 N32 O21 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000331 | | Name: | N-[(benzyloxy)carbonyl]-L-alpha-aspartyl-L-alpha-glutamyl-L-valyl-L-aspartic acid | | Formula: | C26 H34 N4 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000332 | | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | | Formula: | C36 H46 N6 O13 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000333 | | Name: | Nalpha-[(benzyloxy)carbonyl]-N-[(1S)-3-chloro-1-methyl-2-oxopropyl]-L-phenylalaninamide | | Formula: | C21 H23 Cl N2 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001109 | | Name: | peptide ligand | | Formula: | C35 H51 Cl N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000334 | | Name: | BENZYLOXYCARBONYL-GLYCYL-PHENYLALANYL-METHYLENYLGLYCYL DERIVATIVE | | Formula: | C22 H24 Cl N3 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001110 | | Name: | N-[(2R)-1-{[(2S,3S)-5-{[(2R)-1-{[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino}-3-chloro-1-oxopropan-2-yl]amino}-3-hydroxy-5-oxo-1-phenylpentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | | Formula: | C31 H43 Cl N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000335 | | Name: | DEHYDRO-ILE-ALA-ARG-SER | | Formula: | C26 H42 N7 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001111 | | Name: | peptide ligand | | Formula: | C35 H50 Cl2 N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000336 | | Name: | Cbz-Leu-Glu-Thr-AAsp-CHCH-CON-tetrahydroquinoline | | Formula: | C38 H50 N6 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001112 | | Name: | D-phenylalanyl-N-(pyridin-3-ylmethyl)-L-prolinamide | | Formula: | C20 H24 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000337 | | Name: | BENZYLOXYCARBONYL-LEUCINE-VALINE-GLYCINE-METHYLENE | | Formula: | C22 H31 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001113 | | Name: | N-[(2S)-1-{[(2S,3S)-3-hydroxy-5-oxo-5-{[(2R)-1-oxo-3-phenyl-1-(prop-2-yn-1-ylamino)propan-2-yl]amino}-1-phenylpentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | | Formula: | C34 H39 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000338 | | Name: | N-[(benzyloxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide | | Formula: | C21 H28 F N3 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001114 | | Name: | N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-Nalpha-[(2E)-3-phenylprop-2-enoyl]-L-phenylalaninamide | | Formula: | C27 H28 N2 O3 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_001115 | | Name: | N-[(2S)-1-({2-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]ethyl}amino)-1-oxo-3-phenylpropan-2-yl]-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-7-carboxamide | | Formula: | C27 H24 Cl N7 O3 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000339 | | Name: | CARBOBENZOXY-DEHYDRO-VAL-ALA-ARG-SER | | Formula: | C25 H40 N7 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
